Navigation Links
Global Biopharma Mergers & Acquisition and Deal Making Report 2013: Understanding the Latest Trends to Optimize Future Strategy
Date:9/25/2013

DUBLIN, September 25, 2013 /PRNewswire/ --

Research and Markets
(http://www.researchandmarkets.com/research/ffq62m/biopharma_manda) has announced the addition of the "Biopharma M&A and Deal Making: Understanding the Latest Trends to Optimize Future Strategy" report to their offering.

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The report, Biopharma M&A and Deal Making, was written to support team and corporate strategic initiatives around the options that exist to grow revenues through externalization, whether by M&A or licensing. CBR Pharma Insights provides in-depth analysis on the deals being done today, the trends being seen over time, and the strategies employed throughout the industry.

The leading pharmaceutical players continue to face the combined threats of a difficult operating environment and patent losses while struggling to deliver on pipeline potential. Externalization strategies are a key means to boost future revenues and, indeed more imminently, to satisfy shareholder demands. However, the increasing size of the leading biopharmaceutical companies is necessitating their involvement in growing the numbers and size of deals year by year. This in itself, along with the rising financial firepower of the mid-tier players, has increased the level of competition for the most attractive targets.

Increased competition in the marketplace for M&A and licensing deals can artificially inflate the cost of these deals, distorting the balance of value, risk and return. As a result companies must employ more rigorous selection processes and expand search criteria to consider more diverse options if they are to maximize their returns on investment.

Key Reasons to Purchase

- Understand and evaluate the strategies being used by companies of all sizes to support future revenue growth
- Benefit from CBR's case study analysis of the different types of deals being done in the current & future biopharma industry
- Access data and trends analysis of the types of deals taking place and which therapeutic areas are showing the most activity
- Gain insights around the steps that need to be taken in order to best secure a successful deal
- Learn who the key companies are to watch for in the coming year, the motivations behind the deals they are doing, and identify which ones relate to your business strategies

Key Topics Covered:

Chapter 1: Introduction
- What is driving the increased use of externalization in biopharma industry strategies
- Externalization strategies: the options
- Benefits of different deal types from M&A to arm's length licensing

Chapter 2: Trends in recent deal activity
- M&A deal trends
- Key acquisitions in 2012 and the motives behind them
- Most acquisitive companies
- Licensing deal trends (Type of deal, Therapy area, Phase)
- Divesting - the other extreme
- Focus on: Deal activity in the generics sector

Chapter 3: Successful deal making
- Key steps to successful deal making
- Shift to earlier stage deals
- Differentiating capabilities to position company as "partner of choice"
- Focus on: Joint ventures in emerging markets

Chapter 4: Future deal activity
- Key companies to watch in 2013

Appendix


For more information visit http://www.researchandmarkets.com/research/ffq62m/biopharma_manda.

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals


'/>"/>
SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Genomics Group (G3) and Illumina to Partner on Cardiovascular Genomics
2. Health Care Equipment & Supplies: Global Industry Guide
3. Sequenom Announces Global Certified Service Provider Program
4. InspireMD Appoints David Blossom as Vice President of Global Marketing and Strategy
5. Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes and Vials
6. Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging - Focus on Contract Packaging
7. Shire to Present at the Bank of America Merrill Lynch Global Health Care Conference
8. Synthetic Biologics to Present at the First Global Life Sciences Conference in Warsaw, Poland
9. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch Global Healthcare Conference
10. Quest Diagnostics to Speak at the Morgan Stanley Global Healthcare Conference
11. Shire to Present at the Morgan Stanley Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today that it has acquired Agalimmune Ltd., a private UK-based ... of a $6 million upfront payment, of which $3 million ... future payments may be made based on development and commercial ... ...
(Date:3/23/2017)... , March 23, 2017 Pre-market today, ... Allergan PLC (NYSE: AGN), Horizon Pharma PLC (NASDAQ: HZNP), and ... Drugs stocks are part of the Healthcare sector, which was ... , 2017, with the NYSE Health Care Index adding about ... the S&P 500 also were up nearly 0.1% as a ...
(Date:3/23/2017)... , March 23, 2017 /PRNewswire/ - Medicure Inc. ... Canadian specialty pharmaceutical company, is pleased to announce ... final approval from the U.S. Food and Drug ... application ("ANDA") for tetrabenazine tablets in the 12.5 ... product is a generic equivalent of the branded ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... GeBBS ... iCode Assurance, at HCCA’s 21st annual Compliance Institute on March 26-28 in National ... process for all medical chart types with a comprehensive set of features including ...
(Date:3/23/2017)... ... March 23, 2017 , ... “Beyond and Back”: a true-life ... is the creation of published author Bonetta Rose, a wife, mother and grandmother committed ... Published by Christian Faith Publishing, Bonetta Rose‘s new book presents actual events in the ...
(Date:3/23/2017)... ... 23, 2017 , ... “My Journey Through Heaven”: the true-life account of a ... faith of God’s promise of Heaven for His people. “My Journey Through Heaven” is ... his wife, three children and six grandchildren living and doing for God as best ...
(Date:3/23/2017)... ... March 23, 2017 , ... “A Respectful Response To Atheist ... To Atheist Manifesto” is the creation of published author Richard Hostetter, a former ... years. He holds graduate degrees from Kent State University and the University of ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... “More Corruption”: a simple and strong ... who is one of the rulers of Heaven was asked by God to write a ... as discrimination against me just because I kept my commitment to the Lord God. They ...
Breaking Medicine News(10 mins):